BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia

Partnering, Press Releases

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia Creation of a joint venture in Hong Kong Injection of US$20 million by the consortium of Asian investors Start of clinical operations in early 2026 A landmark Memorandum of Understanding (MoU) has…

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101

Press Releases, Partnering, Partnering, Press Releases

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101 Biophytis announces that it has entered exclusive negotiations with a leading Chinese pharmaceutical company. The purpose of these discussions is to finalize a licensing agreement to co-develop and commercialize BIO101 (20-Hydroxyecdysone) in China for its most promising and advanced indications: viral respiratory infections,…

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million

Uncategorized

Biophytis announces the signature of an exclusive license agreement with Blanver, one of the leading and most trusted pharmaceutical company in Brazil, for BIO101 (20-Hydroxyecdysone) in Latin American including, but not limited to Brazil, Mexico, Argentina and Colombia. Biophytis to receive upfront and milestones payments for a total amount up to €108 million, as well…

Biophytis and the University of Liège explore the potential of Sarconeos (BIO101) in the treatment of viral respiratory failure

Partnering, Press Releases

Biophytis and the University of Liège explore the potential of Sarconeos (BIO101) in the treatment of viral respiratory failure Biophytis announces the signing of a new partnership with the University of LieÌ€ge to carry out a range of preclinical research projects, particularly in the treatment of respiratory failure caused by the flu virus Influenza. Under…